Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14867055 | 0.89 | MAPT (0.41) | ALDH1A1POLBMAPTTDP1L3MBTL1 | |
| SCHEMBL23664989 | 0.88 | PPARG (0.33) | ALDH1A1POLBMAPTTDP1L3MBTL1 | |
| SCHEMBL13048615 | 0.83 | ALDH1A1 (0.35) | ALDH1A1POLBMAPTTDP1L3MBTL1 | |
| SCHEMBL21141921 | 0.81 | ALDH1A1 (0.34) | ALDH1A1POLBMAPTTDP1L3MBTL1 | |
| SCHEMBL21141917 | 0.81 | ALDH1A1 (0.46) | ALDH1A1POLBMAPTTDP1L3MBTL1 | |
| Lithium Ion SCHEMBL30085325 | 0.80 | POLB (0.33) | ALDH1A1POLBMAPTTDP1L3MBTL1 | |
| SCHEMBL2742186 | 0.77 | TDP1 (0.42) | ALDH1A1POLBMAPTTDP1L3MBTL1 | |
| SCHEMBL8644283 | 0.73 | ALDH1A1 (0.42) | ALDH1A1POLBMAPTTDP1L3MBTL1 | |
| SCHEMBL14655816 | 0.71 | ALDH1A1 (0.41) | ALDH1A1POLBMAPTL3MBTL1HIF1A | |
| SCHEMBL24248347 | 0.71 | ALDH1A1 (0.38) | ALDH1A1MAPTL3MBTL1HIF1AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309369-A1 | Organic Light-Emitting Device | LG CHEM, LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| US-11737300-B2 | Coating composition and organic light-emitting device | LG CHEM, LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20230043088-A1 | Organic Light Emitting Device | LG CHEM, LTD. (KR) | 2023-02-09 | — | — | US | disclosed |
| US-11165037-B2 | Organic light-emitting diode | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165037-B2 | Organic light-emitting diode | L3MBTL3, CRY2, ALDH1A2 | ALDH1A1 109/4885POLB 1334/4885MAPT 1281/4885 |
| US-11737300-B2 | Coating composition and organic light-emitting device | CD59, CLTB, EPCAM | ALDH1A1 2135/4885POLB 690/4885MAPT 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.